These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3666030)

  • 1. Cholecystokinin facilitates ejaculation in male rats: blockade with proglumide and apomorphine.
    Pfaus JG; Phillips AG
    Eur J Pharmacol; 1987 Sep; 141(3):331-8. PubMed ID: 3666030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophysiological studies on the specificity of the cholecystokinin antagonist proglumide.
    Chiodo LA; Freeman AS; Bunney BS
    Brain Res; 1987 May; 410(2):205-11. PubMed ID: 3036308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal by cholecystokinin of apomorphine-induced inhibition of dopamine release in the nucleus accumbens of the rat.
    Blaha CD; Phillips AG; Lane RF
    Regul Pept; 1987 Jun; 17(6):301-10. PubMed ID: 3602473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of sulfated cholecystokinin octapeptide and proglumide injected intrathecally on antinociception induced by beta-endorphin and morphine administered intracerebroventricularly in mice.
    Suh HH; Tseng LF
    Eur J Pharmacol; 1990 Apr; 179(3):329-38. PubMed ID: 2142090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of morphine analgesia by the cholecystokinin antagonist proglumide.
    Watkins LR; Kinscheck IB; Mayer DJ
    Brain Res; 1985 Feb; 327(1-2):169-80. PubMed ID: 3838690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of proglumide on mesolimbic and nigrostriatal dopamine function.
    Csernansky JG; Glick S; Mellentin J
    Psychopharmacology (Berl); 1987; 91(4):440-4. PubMed ID: 3108924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo electrochemical analysis of cholecystokinin-induced inhibition of dopamine release in the nucleus accumbens.
    Lane RF; Blaha CD; Phillips AG
    Brain Res; 1986 Nov; 397(1):200-4. PubMed ID: 3801862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of proglumide on cholecystokinin-, bombesin-, and glucagon-induced satiety in the rat.
    Collins S; Walker D; Forsyth P; Belbeck L
    Life Sci; 1983 May; 32(19):2223-9. PubMed ID: 6843294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further studies on the specificity of proglumide as a selective cholecystokinin antagonist in the central nervous system.
    Bunney BS; Chiodo LA; Freeman AS
    Ann N Y Acad Sci; 1985; 448():345-51. PubMed ID: 2862828
    [No Abstract]   [Full Text] [Related]  

  • 10. Stimulation of dopamine autoreceptors elicits "premature ejaculation" in rats.
    Napoli-Farris L; Fratta W; Gessa GL
    Pharmacol Biochem Behav; 1984 Jan; 20(1):69-72. PubMed ID: 6695002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholecystokinin antagonists inhibit in vivo voltammetric signals generated by KCl-induced slow wave depolarization in rat caudate.
    Wilkerson JW; Kasser RJ; Renner KJ
    Brain Res; 1992 Oct; 594(1):47-55. PubMed ID: 1467941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholecystokinin potentiates dopamine-mediated behaviors: evidence for modulation specific to a site of coexistence.
    Crawley JN; Stivers JA; Blumstein LK; Paul SM
    J Neurosci; 1985 Aug; 5(8):1972-83. PubMed ID: 4040554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for dopaminomimetic effect of intrastriatally injected cholecystokinin octapeptide in mice.
    Worms P; Martinez J; Briet C; Castro B; Biziere K
    Eur J Pharmacol; 1986 Mar; 121(3):395-401. PubMed ID: 3699101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blocking of cholecystokinin octapeptide behavioral effects by proglumide.
    Katsuura G; Hsiao S; Itoh S
    Peptides; 1984; 5(3):529-34. PubMed ID: 6089145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the CCK-A receptor antagonist CR 1409 on the activity of rat midbrain dopamine neurons.
    Zhang J; Chiodo LA; Freeman AS
    Peptides; 1991; 12(2):339-43. PubMed ID: 2067986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholecystokinin octapeptide, proglumide, and passive avoidance in rats.
    Deupree D; Hsiao S
    Peptides; 1987; 8(1):25-8. PubMed ID: 3575151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proglumide, a cholecystokinin antagonist, increases gastric emptying in rats.
    Shillabeer G; Davison JS
    Am J Physiol; 1987 Feb; 252(2 Pt 2):R353-60. PubMed ID: 3812772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the novel cholecystokinin receptor antagonist CR-1392 on cholecystokinin-induced antroduodenal and pyloric motor activity in vivo.
    Allescher HD; Daniel EE; Fox JE; Kostolanska F; Rovati LA
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1134-41. PubMed ID: 2600808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular dopamine in the anterior nucleus accumbens is distinctly affected by ventral tegmental area administration of cholecystokinin and apomorphine: data from in vivo voltammetry.
    Reum T; Fink H; Marsden CA; Morgenstern R
    Neuropeptides; 1998 Apr; 32(2):161-6. PubMed ID: 9639255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiological effects of cholecystokinin octapeptide on identified rat nigrostriatal dopaminergic neurons.
    Freeman AS; Chiodo LA
    Brain Res; 1988 Jan; 439(1-2):266-74. PubMed ID: 3359189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.